Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
1 other identifier
observational
247
1 country
1
Brief Summary
The goal of this observational cross-sectional study is to identify factors associated with severity of acne in Thai transmen receiving masculinizing hormone therapy. The main questions it aims to answer are:
- What are the factors associated with severity of acne in transmen?
- Does masculinizing hormone therapy associate with the severity of acne in transmen? Participants will be asked to complete an online questionnaire and allow to take pictures of their face for acne assessment purpose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2023
CompletedFirst Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 28, 2023
CompletedNovember 28, 2023
November 1, 2023
2 years
November 20, 2023
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The severity of acne
Investigator Global Assessment (IGA) scale for acne
1 day (At the time of answering an online questionnaire)
Interventions
Masculinizing hormone therapy (testosterone) is used in female-to-male transgenders for medical reason.
Eligibility Criteria
All transmen who visited the Gender Variation (GenV) Clinic (outpatient clinic) of Ramathibodi Hospital
You may qualify if:
- Transmen who visited the Gender Variation (GenV) Clinic of Ramathibodi Hospital
- Transmen who received masculinizing hormone therapy (testosterone)
- Transmen who completed an online questionnaire and intentional submit their facial photographs
You may not qualify if:
- Refusal to participate
- Incomplete questionnaire
- Missing photos
- Diagnosis of any disorders of sexual differentiation which may have peculiar hormonal effect
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Ratchathewi, Bangkok, 10400, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 17 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 28, 2023
Study Start
June 5, 2021
Primary Completion
June 6, 2023
Study Completion
June 6, 2023
Last Updated
November 28, 2023
Record last verified: 2023-11